Reflect & Connect: Research Before, During and After COVID19
Over five days in May this Virtual Event will cover three Streams on each of the days. There are 14 sessions each of 45 minutes duration over the course of the week. The streams are:
- Policy & Decision Making (12:00 each day)
- Inside COVID19 Research (14:00 each day)
- Making Research Happen (17:00 each day)
Programme
Monday 17th May
When science takes centre stage
Presenters:
Professor Jonathan Van-Tam (Deputy Chief Medical Officer, Department of Health and Social Care)
Louise Wood CBE (Director of Science, Research & Evidence, Department of Health and Social Care)
Professor Jonathan Van-Tam
Professor Jonathan Van-Tam was appointed Deputy Chief Medical Officer in October 2017. He leads on health protection.
Career highlights:
• Clinical experience in emergency medicine, anaesthesia, general medicine and infectious diseases
• Clinical academic training in public health medicine
• Became Clinical Senior Lecturer at Nottingham in 1997
• Worked in the pharmaceutical and vaccines industries from 2000 (SmithKline Beecham 2000 to 2001, Roche Products Ltd 2001 to 2002 and Sanofi-Pasteur MSD 2002 to 2004)
• Became Consultant Epidemiologist and Head of the Pandemic Influenza Office at the UK Health Protection Agency in 2004
• Returned to Nottingham in 2007 as Clinical Professor of Health Protection
• Consultant to the World Health Organization on influenza since 2004
• Sat on the UK Scientific Advisory Group for Emergencies (SAGE) during the 2009 to 2010 pandemic crisis and afterwards
• Chair of UK New and Emerging Respiratory Virus Threat Advisory Group (NERVTAG), 2014 to 2017
Louise Wood CBE
Louise is Director of Science, Research & Evidence at the Department of Health and Social Care. She has led the National Institute for Health Research (NIHR) with Prof Chris Whitty, the Department’s Chief Scientific Advisor, since 2016 and also has responsibility for policy research and science policy. Previously, she held several roles in the Department’s R&D Directorate, including Deputy Director leading on relations with the life sciences industry, and subsequently for research infrastructure in the NHS and partner universities to support delivery of ground-breaking research to improve patient care and population health and cement the UK’s reputation as a leading international centre for healthcare research and science. She spent her early career working at the Medicines and Healthcare products Regulatory Agency and served on the Agency’s Executive Board for four years as founding Director of the General Practice Research Database, forerunner to the Clinical Practice Research Datalink. More recently Louise spent a year on secondment at the Association of Medical Research Charities as its Director of Policy and Public Affairs.
Since 2018, Louise has served as a Council Member for the Medical Research Council and as a member of the Advisory Board to the Wellcome Centre for Cultures and Environments of Health at the University of Exeter. She was elected an honorary fellow of the Faculty of Pharmaceutical Medicine in 2011 and awarded a CBE for services to health research in the 2019 Queen’s Birthday Honours.
Inside the COVID19 vaccine trials delivery programme
Presenter: Professor Andrew Ustianowski (Research Lead and Consultant in Infectious Diseases & Tropical Medicine, North Manchester General Hospital)
Find out more about the speakerProfessor Andrew Ustianowski is a Consultant Physician in Infectious Diseases and Tropical Medicine at the Regional Infection Unit, North Manchester General Hospital, UK; the Deputy Clinical Director in Greater Manchester Clinical Research Network; and Joint National Specialty Lead for Infection for the UK National Institute of Health Research.
Currently he is the national clinical lead for the UK NIHR COVID Vaccine Research Programme, is UK chief investigator on 7 COVID studies and has been an investigator on multiple other SARS-CoV2 trials. He is a member of the national NIHR Urgent Public Health Committee.
Dr Ustianowski graduated from Guy’s Hospital, London, UK and subsequently trained in Infectious Diseases, Tropical Medicine, HIV and General Medicine in the London region.
Recognising the contribution and impact of the nurse and midwifery research workforce throughout Covid-19
Presenter: Mark Radford (Chief Nurse, Health Education England)
Find out more about the speakerMark Radford is Chief Nurse at HEE and Deputy Chief Nursing Officer for England. Mark has worked in perioperative, emergency and intensive care in the UK and Europe. He has previously been Chief Nurse of a University Teaching Hospital and Consultant Nurse in emergency and trauma care. Mark is Professor of Nursing at Birmingham City and Coventry Universities, and has published research on staffing, advanced practice, perioperative and trauma care.
Tuesday 18th May
Integrating, Improving, Innovating
Presenter: Janet Messer (Director of Approvals Service, Health Research Authority)
Find out more about the speakerJanet Messer is Director of Approvals Service at the Health Research Authority. She is responsible for the Research Ethics, Confidentiality Advice, Assessment and Assurance services, alongside the supporting guidance, advice and learning functions. Her team works collaboratively with a wide range of partner organisations to fulfil the HRA’s aims to make it easier to do good quality ethical research in the UK. She has a PhD in biochemistry from University of Cambridge, a Masters in Medical Law, along with many years’ experience of clinical research in the pharmaceutical industry, NHS R&D and the NIHR Clinical Research Network.
Inside PRINCIPLE
Presenter: Professor Christopher Butler (Professor of Primary Care, Primary Care Clinical Trials Unit, University of Oxford)
Find out more about the speakerChris Butler is the Clinical Director of the University of Oxford Primary Care and Vaccines Clinical Trials Collaborative, and of the NIHR Community Healthcare Medical Technology and In-Vitro Diagnostics Co-operative.
His main research interests are in common infections (especially the appropriate use of antivirals and antibiotics, and point of care diagnostics), and health care communication and behaviour change. He has expertise in clinical trials, cohort studies, qualitative research and analysis of routinely collected data. He chairs the £10M Longitude Prize Advisory Panel.
He practices as a GP in Mountain Ash in South Wales, and won the patient-nominated RCGP Wales General Practitioner or the Year award in 2019.
He currently leads the UK National Urgent Public Health Priority Platform Community Clinical Trial of interventions for earlier on in Covid-19-like-illness illness (The Principle Trial: https://www.principletrial.org)
Public Involvement in a Public Health Emergency
Presenter: Jim Elliott (Public Involvement Lead, Health Research Authority)
Find out more about the speakerJim provides leadership to the Health Research Authority on the involvement of patients and the public in health research [part time] as part of his work as an advocate for patients in research. He has been a carer for close family with cancer and other health conditions for many years. His career has been spent in health research management across the commercial, public and voluntary sectors. His combined experiences have led to an interest in helping to ensure that patients and the public can make a contribution to the design, conduct and management of health research. Jim is currently involved as a public contributor in the work of Cancer Research UK, the Wales Cancer Research Centre, Genomics Partnership Wales and two research projects at the Health Services Research Unit at the University of Aberdeen on the retention of patients in clinical trials and is a public involvement adviser to the Good Clinical Trials Collaborative. His involvement in research also includes being a member of the Consumer Forum of the National Cancer Research Institute, Independent Cancer Patients’ Voice and Health and Care Research Wales’ public involvement community.
Wednesday 19th May
The future of R&D in the UK
Presenters:
Emma Lowe (Research Policy Senior Manager, DHSC)
Carys Thomas (Head of R&D Policy, Welsh Government)
Emma Lowe
Emma works within the Science, Research and Evidence Directorate at the Department of Health and Social Care, and leads delivery of the cross-sector UK Clinical Research Recovery Resilience and Growth Programme.
Emma has an MSc in People and Organisational Development from the Roffey Park Institute, has held a variety of roles within the NHS and previously led the design and delivery of learning and workforce development programmes in the NIHR Clinical Research Network, including the NIHR’s Good Clinical Practice (GCP) programme.
Carys Thomas
Carys is the Head of R&D Policy at the Health and Social R&D Division in Welsh Government and oversees key strategic areas including NHS and social care R&D strategy and funding, industry engagement, digital, and public involvement and engagement.
Prior to joining Welsh Government in 2002, she was a senior researcher at the Home Office and has also worked in research roles at the Cabinet Office, and National Savings and Investments.
Inside RECOVERY
Presenter: Professor Martin Landray (Professor of Medicine & Epidemiology, Nuffield Department of Population Health, University of Oxford)
Find out more about the speakerMartin Landray is Professor of Medicine & Epidemiology at the Nuffield Department of Population Health and Acting Director at the Big Data Institute, University of Oxford, UK. He leads the clinical trials programme for Health Data Research UK and NHS DigiTrials, the national health data hub for clinical trials. His research focuses on the use of digital technology and quality-by-design principles for large randomized trials of treatments for cardiovascular and kidney disease. He is co-chief investigator of the RECOVERY trial, the national priority platform trial of potential treatments for patients hospitalised with COVID-19 in the UK.
Prof Landray is heavily involved in international efforts to streamline clinical trials and the guidelines and regulations that govern their conduct. He is a member of the European Society of Cardiology Regulatory Affairs Committee and leads the Good Clinical Trials Collaborative, supported by Wellcome Trust, Bill & Melinda Gates Foundation and African Academy of Sciences.
Cost of COVID
Presenters:
Dr Phillip Smith (Associate Director of Research and Development, UKRD/R&D Forum Finance Group)
Gillian Chater (Assistant Finance Director – Research, The Newcastle upon Tyne Hospitals NHS Foundation Trust)
Susan Keenan (R&D Senior Finance Manager, University Hospital Southampton)
Dr Phillip Smith
Phillip has been Associate Director of Research and Development at East and North Hertfordshire NHS Trust since Nov 2015. During that time his leadership saw the development and successful implementation of the Trust’s Research Strategy which seeks to enhance patient experience and outcome through research and innovation. Phillip and Christine McGrath set-up the UKRD and NHS R&D Forum Finance Managers group which is seeking to increase ensure that we, as a nation, can make best use of research funding to support research.
Prior to this Phillip has worked for the National Institute for Health Research from 2008 to 2015. This followed a three year role as Assistant Director for Research and Intellectual Property for the Ipswich Hospital NHS Trust (also covered Primary Care and Mental Health in Suffolk). Phillip has also delivered a number of other roles including: Visiting Professor at the University of Hertfordshire, Innovation Ambassador at the Eastern Academic Health Science Network, Co-chair of the NHS R&D Forum Strategy Group, National Governance Lead for the NIHR Clinical Research Network Pandemic Flu Coordinating Group, Senior Research Fellow within the Centre for Research in Health and Social Care, Anglia Ruskin University, Scientific Officer for the Mid Essex NHS Research Ethics Committee.
Along the way Phillip has also applied his skills to the voluntary sector and spent 4 years as Chair of Governors for a local primary school.
Gillian Chater
A Chartered Management Accountant with over 35 years NHS Finance experience. Gillian worked in various Trusts in a number of roles – Head of Financial Management, Financial Accountant for Charitable Funds, Clinical Directorate Finance Manager, Assistant Finance Director for Financial Management and currently Assistant Finance Director for Research. Gillian is passionate about the future of the Finance function in the NHS, a Future Focussed Finance Value Maker, Finance and Clinical Educator and Skills Development Lead. Gillian develops finance teams to become effective business partners to service delivery managers to improve the quality and sustainability of healthcare services.
Susan Keenan
Susan entered the research arena as R&D Senior Finance Manager at University Hospital Southampton in 2014. Her responsibilities include the development and delivery of financial strategy and comprehensive financial management of R&D income and expenditure. She is a fully qualified chartered accountant with vast experience of working as financial lead within the public sector. In 2019 Susan established and is chair of the UK Finance Managers Group (URD / RD Forum) which is a professional community of NHS R&D Finance Managers. It was created specifically to explore and discuss topical and ongoing issues facing NHS R&D departments, how they impact on individual Trusts and the R&D community as a whole.
Thursday 20th May
Regulation for the future
Presenter: Martin O’Kane (Head of Clinical Trials Unit, MHRA)
Find out more about the speakerDr Martin O’Kane MRPharmS is Unit Manager of the Clinical Trials Unit in the Licensing Division of the Medicines and Healthcare products Regulatory Agency (MHRA). He studied pharmacy at University of Aston and after completing a PhD in pharmacology and post-doctorate neuroscience research project at the University of Glasgow, moved to Japan to work within the pharmaceutical industry. He joined the MHRA in 2005 as a Pharmacopoeial Scientist within the British Pharmacopoeia and moved to the MHRA Clinical Trials Unit as a Pharmaceutical Assessor in 2007. He became Unit Manager of the Clinical Trials Unit in November 2015 and has been actively involved in development of new clinical trials systems and procedures and well as the UKs exit from the EU. Most recently he has been involved in supporting expedited approval of clinical trials for COVID-19 vaccines and therapeutics and the recovery and resilience of non-COVID trials.
Inside REMAP-CAP
Presenter: Professor Anthony Gordon (Chair in Anaesthesia and Critical Care and Consultant in Intensive Care Medicine, Imperial College)
Find out more about the speakerProfessor Gordon is the Chair of Anaesthesia and Critical Care at Imperial College London and an intensive care consultant based at St Mary’s Hospital. He is a Director of Research for the UK Intensive Care Society and is Chair of the NIHR Critical Care Experimental Medicine group. He is a founding member of the UK Critical Care Research Group.
His research interest focuses on translational research in sepsis. He has been an NIHR Clinician Scientist and the Chief Investigator for a number of multi-centre septic shock trials. He is now an NIHR Research Professor, leading a multi-disciplinary team investigating personalised medicine in sepsis. He is the UK Chief Investigator for REMAP-CAP, an international multi-factorial Bayesian adaptive platform trial designed for pandemic infection, including COVID-19.
The future of industry research and rebuilding the charity sector
Presenters:
Dr Sheuli Porkess (Interim Medical Director, The Association of the British Pharmaceutical Industry)
Hilary Reynolds CBE (Interim CEO, AMRC)
Dr Sheuli Porkess
Dr Sheuli Porkess is the Interim Medical Director at the Association of the British Pharmaceutical Industry and co-Chair of the Advisory Group to the DHSC Clinical Research Recovery, Resilience & Growth Programme. She is also Director of Actaros Consultancy and Chair of the Policy and Communications Group at the Faculty of Pharmaceutical Medicine.
Sheuli is an experienced pharmaceutical physician and her career began in clinical medicine in the NHS. Sheuli has held a number of medical leadership roles in companies at a national, regional and international level, living and working in different countries as well as expertise in policy development within the UK and internationally. Sheuli is a Fellow of the Faculty of Pharmaceutical Medicine in the UK and a Global Fellow in Medicine Development with IFAPP.
Hilary Reynolds CBE
Hilary Reynolds has taken on the role of Interim CEO, having joined AMRC in November 2020 as senior project lead for policy development.
Hilary joined the civil service in 1986 working in policy and operational roles at the social welfare, pensions and health departments, operating at Director level since 2000 and completing an MBA from Brunel University in 2003. Between 2008 -2011 she went on a 3 year secondment to the New Zealand government as Deputy Chief Executive at the Ministry for Social Development. She was the Director of Change for the Care Quality Commission 2013-15 and the Executive Director for Research Councils UK 2015-17. Hilary was awarded a CBE for her services to public policy and research in the New Year’s Honours 2018.
She left public service in 2017 to take up the role of Executive Director for Strategy and Research with the Stroke Association during which time she was a member-elected Trustee of the AMRC.
She has recently completed her maximum term as Trustee for ChanceUK, a London charity providing mentoring to children at risk of exclusion from school; and volunteers on her non-working Fridays at her local community high school (currently processing covid19 tests for staff and pupils attending in person).
Friday 21st May
Restart, Recovery and R&D
Presenters:
Dr William van’t Hoff (Chief Executive Officer, NIHR Clinical Research Network)
Angela Topping (Head of the Newcastle Joint Research Office (NJRO), Newcastle University/The Newcastle upon Tyne Hospitals NHS Foundation Trust)
Dr William van’t Hoff
Dr William van’t Hoff is the Chief Executive Officer at the NIHR Clinical Research Network (CRN) Coordinating Centre. He took up this position in March 2020. In his role, he provides leadership to the Clinical Research Network across England. Working in partnership, the Network delivers thousands of research studies with approximately 1 million participants each year, in the NHS as well as in social care settings throughout the country.
His previous post was as a Consultant Paediatric Nephrologist and Director of the NIHR Clinical Research Facility at Great Ormond Street Hospital, London.
William has worked in NIHR since 2006, holding a number of positions. He is committed to patient involvement, inclusion and delivering the best research to maximise patient benefit. As NIHR CRN Clinical Director for NHS Engagement, he led an innovative partnership, including the R&D community and patients, to integrate clinical research into the CQC’s assessments of hospitals.
Angela Topping
Angela Topping is Head of the Newcastle Joint Research Office (NJRO) – a Partnership between Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust and Deputy Director of Research Strategy and Development at Newcastle University. In her role as Head of NJRO, Angela leads a team of University and Trust colleagues who work with researchers to develop, deliver and implement world class clinical research into healthcare practice. Team Science, Collaboration, Systems Leadership approach to research and providing opportunities for colleagues to flourish are fundamental to the success of Translational Research at Newcastle. Angela has been Head of the NJRO since 2018, having been Faculty Accountant (ACMA CGMA) in the Faculty of Medical Sciences at Newcastle University for over 18 years.
Angela is a Fellow of the Newcastle University Policy Academy, and works with the NHS R&D Forum and ARMA to bring together the R&D communities across the Academic/NHS Interface to form a network to share best practice, opportunities and learning.
Inside PHOSP-COVID
Presenter: Professor Chris Brightling (Professor in Respiratory Medicine, Department of Respiratory Sciences, University of Leicester)
Find out more about the speakerChris Brightling is a National Institute for Health Research Senior Investigator, Fellow of the Academy of Medical Sciences, Respiratory Theme Lead for Leicester NIHR Biomedical Research Centre, Director Institute for Lung Health and Honorary Consultant Respiratory Physician, Leicester, UK. He is COVID-19 Leicester research lead, CI PHOSP-COVID, local PI for RECOVERY trial and ERS COVID-19 Clinical Research Collaboration co-chair.
He is Coordinator for the European Union Consortium AirPROM, MRC/ABPI COPD (COPDMAP) Consortium, the MRC Molecular Pathology Node EMBER and Respiratory lead for the IMI 3TR. He was founding Director of the European Respiratory Society Clinical Research Collaborations and is the current ERS Science Council Chair. His research focusses on improving the clinical management and understanding the immunopathogenesis of the airway diseases asthma, chronic cough and COPD. He has published over 390 peer-reviewed articles and has an h-index of 100 (google scholar). He is a member of the American College of Chest Physicians’ Cough Guidelines, the British Thoracic Society, American Thoracic Society/European Respiratory Society Severe Asthma guidelines and is on the scientific committee for the Global INitiative for Asthma – GINA.
Frequently Asked Questions
To register to attend Reflect & Connect please click the button at the bottom of this page.
Registration is £100 (+VAT) per person. This fee covers attending all 5 days of the event and also gives access to the recorded sessions after the event.
You can attend as many of the sessions as you want. If you are unable to attend a specific session you can watch the recording of the session at a later date.
Prior to the event you will be sent a login to a webpage. This webpage will direct you the sessions that you can view online.
Yes. We will be having live Q&A in as many of the sessions as possible.